These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 26915853)

  • 21. Hyperdynamic circulation in cirrhosis: predictive factors and outcome following liver transplantation.
    Siniscalchi A; Aurini L; Spedicato S; Bernardi E; Zanoni A; Dante A; Cimatti M; Gamberini L; Faenza S
    Minerva Anestesiol; 2013 Jan; 79(1):15-23. PubMed ID: 23090103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting stroke volume and arterial pressure fluid responsiveness in liver cirrhosis patients using dynamic preload variables: A prospective study of diagnostic accuracy.
    Wu CY; Cheng YJ; Liu YJ; Wu TT; Chien CT; Chan KC;
    Eur J Anaesthesiol; 2016 Sep; 33(9):645-52. PubMed ID: 27167058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beta-blockers and portal hypertension, hemodynamic effects and prevention of recurrent gastrointestinal bleeding.
    Lebrec D
    Hepatogastroenterology; 1990 Dec; 37(6):556-60. PubMed ID: 1981204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of phlebotomy and phenylephrine infusion on portal venous pressure and systemic hemodynamics during liver transplantation.
    Massicotte L; Perrault MA; Denault AY; Klinck JR; Beaulieu D; Roy JD; Thibeault L; Roy A; McCormack M; Karakiewicz P
    Transplantation; 2010 Apr; 89(8):920-7. PubMed ID: 20216483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemodynamic effects of acute administration of furosemide in patients with cirrhosis receiving beta-adrenergic antagonists.
    Sogni P; Soupison T; Moreau R; Le Moine O; Bacq Y; Hadengue A; Lebrec D
    J Hepatol; 1994 Apr; 20(4):548-52. PubMed ID: 7914215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of Sapropterin on Portal and Systemic Hemodynamics in Patients With Cirrhosis and Portal Hypertension: A Bicentric Double-Blind Placebo-Controlled Study.
    Reverter E; Mesonero F; Seijo S; Martínez J; Abraldes JG; Peñas B; Berzigotti A; Deulofeu R; Bosch J; Albillos A; García-Pagán JC
    Am J Gastroenterol; 2015 Jul; 110(7):985-92. PubMed ID: 26077176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disparate hemodynamic responses to mental challenge after antihypertensive therapy with beta blockers and calcium entry blockers.
    Schmieder RE; Rueddel H; Neus H; Messerli FH; Von Eiff AW
    Am J Med; 1987 Jan; 82(1):11-6. PubMed ID: 2879457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical, laboratory, and hemodynamic parameters in portal hypertensive gastropathy: a study of 254 cirrhotics.
    Kumar A; Mishra SR; Sharma P; Sharma BC; Sarin SK
    J Clin Gastroenterol; 2010 Apr; 44(4):294-300. PubMed ID: 19730114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disagreement between acute and chronic haemodynamic effects of nadolol in cirrhosis: a pathophysiological interpretation.
    Merkel C; Bolognesi M; Sacerdoti D; Bombonato G; Cavasin L; Gatta A
    Aliment Pharmacol Ther; 2005 Sep; 22(5):433-9. PubMed ID: 16128681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vasoconstrictor use in liver transplantation: is there evidence for rational use?
    Skagen CL; Said A
    Minerva Gastroenterol Dietol; 2010 Sep; 56(3):279-96. PubMed ID: 21037546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.
    Abraldes JG; Albillos A; Bañares R; Turnes J; González R; García-Pagán JC; Bosch J
    Gastroenterology; 2009 May; 136(5):1651-8. PubMed ID: 19208350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of fasudil on the portal and systemic hemodynamics of patients with cirrhosis.
    Fukuda T; Narahara Y; Kanazawa H; Matsushita Y; Kidokoro H; Itokawa N; Kondo C; Atsukawa M; Nakatsuka K; Sakamoto C
    J Gastroenterol Hepatol; 2014 Feb; 29(2):325-9. PubMed ID: 24033356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemodynamic changes after administration of mannitol measured by a noninvasive cardiac output monitor.
    Sabharwal N; Rao GS; Ali Z; Radhakrishnan M
    J Neurosurg Anesthesiol; 2009 Jul; 21(3):248-52. PubMed ID: 19543004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical implications of the hyperdynamic syndrome in cirrhosis.
    Licata A; Mazzola A; Ingrassia D; Calvaruso V; Cammà C; Craxì A
    Eur J Intern Med; 2014 Nov; 25(9):795-802. PubMed ID: 25245607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anemia worsens hyperdynamic circulation of patients with cirrhosis and portal hypertension.
    Cirera I; Elizalde JI; Piqué JM; Feu F; Casadevall M; Goldin E; Terés J; Bosch J; Rodés J
    Dig Dis Sci; 1997 Aug; 42(8):1697-702. PubMed ID: 9286236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Capsaicin treatment blocks development of hyperkinetic circulation in portal hypertensive and cirrhotic rats.
    Lee SS; Sharkey KA
    Am J Physiol; 1993 May; 264(5 Pt 1):G868-73. PubMed ID: 8498513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of a Short-Acting β1 Blocker During Endotoxemia May Reduce Cerebral Tissue Oxygenation if Hemodynamics are Depressed by a Decrease in Heart Rate.
    Kurita T; Kawashima S; Morita K; Nakajima Y
    Shock; 2017 Jun; 47(6):765-771. PubMed ID: 28505021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of hemodynamic changes after acute normovolemic hemodilution using Ringer's lactate versus 5% albumin in patients on beta-blockers undergoing coronary artery bypass surgery.
    Arya VK; Nagdeve NG; Kumar A; Thingnam SK; Dhaliwal RS
    J Cardiothorac Vasc Anesth; 2006 Dec; 20(6):812-8. PubMed ID: 17138086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maintenance of hemodynamic response to treatment for portal hypertension and influence on complications of cirrhosis.
    Villanueva C; López-Balaguer JM; Aracil C; Kolle L; González B; Miñana J; Soriano G; Guarner C; Balanzó J
    J Hepatol; 2004 May; 40(5):757-65. PubMed ID: 15094222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beta-blockers.
    Bursey RF
    Can J Gastroenterol; 1998; 12(8):542-3. PubMed ID: 9926263
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.